These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 36525156)
41. [In Vitro Activity of Ceftazidime-avibactam and Colistin Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates]. Hoşbul T; Aydoğan CN; Kaya S; Bedir O; Gümral R; Albay A Mikrobiyol Bul; 2022 Apr; 56(2):218-229. PubMed ID: 35477226 [TBL] [Abstract][Full Text] [Related]
42. Diverse efficacy of CarbaNP test among OXA-48 carbapenemase producing Enterobacterales in an endemic region. Hortaç İştar E; Alışkan HE; Göçmen JS Acta Microbiol Immunol Hung; 2021 Mar; 68(1):34-39. PubMed ID: 33661134 [TBL] [Abstract][Full Text] [Related]
43. Mobile genetic elements-mediated Enterobacterales-associated carbapenemase antibiotic resistance genes propagation between the environment and humans: A One Health South African study. Ramsamy Y; Mlisana KP; Amoako DG; Abia ALK; Ismail A; Allam M; Mbanga J; Singh R; Essack SY Sci Total Environ; 2022 Feb; 806(Pt 3):150641. PubMed ID: 34606866 [TBL] [Abstract][Full Text] [Related]
44. Dual-tubed multiplex-PCR for molecular characterization of carbapenemases isolated among Acinetobacter spp. and Pseudomonas spp. Kazi M; Nikam C; Shetty A; Rodrigues C J Appl Microbiol; 2015 May; 118(5):1096-102. PubMed ID: 25647446 [TBL] [Abstract][Full Text] [Related]
45. Occurrence and Characterization of Carbapenemase-Producing Enterobacteriaceae in a Tunisian Hospital. Ben Helal R; Dziri R; Chedly M; Klibi N; Barguellil F; El Asli MS; Ben Moussa M Microb Drug Resist; 2018 Nov; 24(9):1361-1367. PubMed ID: 29596032 [TBL] [Abstract][Full Text] [Related]
46. OXA beta-lactamase-mediated carbapenem resistance in Acinetobacter baumannii. Amudhan SM; Sekar U; Arunagiri K; Sekar B Indian J Med Microbiol; 2011; 29(3):269-74. PubMed ID: 21860108 [TBL] [Abstract][Full Text] [Related]
47. Occurrence of antibiotic resistance among Zarzecka U; Chajęcka-Wierzchowska W; Zadernowska A Int J Environ Health Res; 2022 Aug; 32(8):1733-1744. PubMed ID: 33784901 [TBL] [Abstract][Full Text] [Related]
48. A Longitudinal Survey of Antibiotic-Resistant Enterobacterales in the Irish Environment, 2019-2020. Hooban B; Fitzhenry K; O'Connor L; Miliotis G; Joyce A; Chueiri A; Farrell ML; DeLappe N; Tuohy A; Cormican M; Morris D Sci Total Environ; 2022 Jul; 828():154488. PubMed ID: 35278563 [TBL] [Abstract][Full Text] [Related]
49. Genetic characterisation of carbapenem-resistant Gram-negative bacteria isolated from the University Hospital Mohamed Boudiaf in Ouargla, southern Algeria. Yagoubat M; Ould El-Hadj-Khelil A; Malki A; Bakour S; Touati A; Rolain JM J Glob Antimicrob Resist; 2017 Mar; 8():55-59. PubMed ID: 28007519 [TBL] [Abstract][Full Text] [Related]
50. Antimicrobial and antibiofilm activity of isoorientin against carbapenem non-sensitive Escherichia coli from raw milk of goats. Zuo J; Liu L; Hou S; Liu X; Teng J; Li P; Liu X J Anim Sci; 2023 Jan; 101():. PubMed ID: 36762933 [TBL] [Abstract][Full Text] [Related]
51. Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant Han R; Shi Q; Wu S; Yin D; Peng M; Dong D; Zheng Y; Guo Y; Zhang R; Hu F; Front Cell Infect Microbiol; 2020; 10():314. PubMed ID: 32719751 [TBL] [Abstract][Full Text] [Related]
52. Ceftazidime-avibactam activity against a challenge set of carbapenem-resistant Enterobacterales: Ompk36 L3 alterations and β-lactamases with ceftazidime hydrolytic activity lead to elevated MIC values. Castanheira M; Doyle TB; Hubler C; Sader HS; Mendes RE Int J Antimicrob Agents; 2020 Jul; 56(1):106011. PubMed ID: 32417206 [TBL] [Abstract][Full Text] [Related]
53. The emergence of bla Moghadampour M; Rezaei A; Faghri J Acta Microbiol Immunol Hung; 2018 Aug; 65(3):335-344. PubMed ID: 30024268 [TBL] [Abstract][Full Text] [Related]
54. Phenotypic and molecular characteristics of carbapenem-non-susceptible Enterobacteriaceae from a teaching hospital in Wenzhou, southern China. Zhou T; Zhang X; Guo M; Ye J; Lu Y; Bao Q; Chi W Jpn J Infect Dis; 2013; 66(2):96-102. PubMed ID: 23514904 [TBL] [Abstract][Full Text] [Related]
55. Detection of Carbapenem-Resistant Genes in Mahmoud NE; Altayb HN; Gurashi RM J Environ Public Health; 2020; 2020():2571293. PubMed ID: 32612664 [TBL] [Abstract][Full Text] [Related]
56. Molecular Epidemiology, Microbial Virulence, and Resistance of Carbapenem-Resistant Peng C; Feng DH; Zhan Y; Wang Q; Chen DQ; Xu Z; Yang L Microb Drug Resist; 2022 Jun; 28(6):698-709. PubMed ID: 35639427 [TBL] [Abstract][Full Text] [Related]
57. Activity of ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam against carbapenemase-negative carbapenem-resistant Enterobacterales isolates from US hospitals. Castanheira M; Doyle TB; Deshpande LM; Mendes RE; Sader HS Int J Antimicrob Agents; 2021 Nov; 58(5):106439. PubMed ID: 34547421 [TBL] [Abstract][Full Text] [Related]
58. Molecular Characterization of Carbapenem-Resistant Enterobacterales Collected in the United States. Karlsson M; Lutgring JD; Ansari U; Lawsin A; Albrecht V; McAllister G; Daniels J; Lonsway D; McKay L; Beldavs Z; Bower C; Dumyati G; Gross A; Jacob J; Janelle S; Kainer MA; Lynfield R; Phipps EC; Schutz K; Wilson L; Witwer ML; Bulens SN; Walters MS; Duffy N; Kallen AJ; Elkins CA; Rasheed JK Microb Drug Resist; 2022 Apr; 28(4):389-397. PubMed ID: 35172110 [TBL] [Abstract][Full Text] [Related]